Every three months the Agency for Health Care Administration sends a report to the Governor's budget office and the two legislators who hold the state's checkbook, and the Legislature's own language tells the agency what to put in it: who the suppliers and importers are, how many drugs are under contract, and "the number of prescriptions dispensed under the program." The newest one covers April through June of 2026. The row that answers the question has two cells in it, and both say "N/A."

That is the receipt. The number next to it is not in the report at all. ClickOrlando read Florida's contract register, which this show has not opened, and reports that the state has paid the program's vendor $81,946,746.74. The station's math on that is "about $1.2 million a month" for "nearly five years." The state's report says the same vendor "has not contracted with a foreign manufacturer." Put the two pages side by side and you have the whole story: the money is the station's reading, the N/A is the agency's own words, and neither one has a pill in it.

The Receipt

The report is a short document. Its first page of text explains why it exists: "Specific Appropriation 191 of Senate Bill 2500," the budget the Legislature passed as Chapter 2025-198, requires AHCA to "submit a quarterly report to the Governor's Office of Policy and Budget, the chair of the Senate Committee on Appropriations, and the chair of the House of Representatives Budget Committee within 30 days after the last business day of the preceding quarter." The report is supposed to detail "a list of participating suppliers and importers, the number of unique prescription drugs available under negotiated contracts, and the number of prescriptions dispensed under the program."

Then it tells the history in its own words. "In 2019, Governor DeSantis signed House Bill 19 (Prescription Drug Importation Programs), creating Section 381.02035, Florida Statutes." The law told the agency to find one vendor to import drugs from Canada for people in state-run programs, with Florida Medicaid as the example the report gives. Florida sent its plan to the FDA in November 2020. In December 2020 the agency "procured and contracted with an importer to serve as the single vendor." A Canadian wholesaler, the foreign seller, joined in April 2021. The plan, the report says, "contains 14 medications of varying strengths and dosage forms."

Now the tables, on the third page. Under supply chain partners for Q2 2026: "LifeScience Logistics," category "Importer." The foreign seller: "Confidential," with the asterisk explaining that "The Vendor asserts that the identity of the foreign seller is proprietary and confidential." Under unique drugs imported per manufacturer: "N/A." The footnote, in full: "The Vendor, as defined in 381.02035 (l), F.S., has not contracted with a foreign manufacturer for reasons cited earlier in this report."

That is the entire data section of a report the Legislature ordered so it would know how many prescriptions got filled. A vendor named, a seller it will not name, and a manufacturer count of N/A.

Why It Costs You

The report carries no dollar figure. Not a contract amount, not a payment to date, not a monthly rate. For that you have to go where ClickOrlando went, which is the state's contract tracking system. The station reports that "When no company bid to run the program, the state's Agency for Health Care Administration (AHCA) negotiated a contract with Dallas-based LifeScience Logistics. That contract, signed Dec. 30, 2020, started at $38.8 million. Two years later, the state renewed it and added $43.5 million." And the total, per the station: "According to Florida's contract tracking system, the state has paid LifeScience $81,946,746.74."

Say that figure the way the station does, because the register is theirs to have read and not ours. Nearly $82 million, by ClickOrlando's reading of the register, paid by the state that runs the Medicaid program the drugs were supposed to help. The station also reports who the drugs were for: "state programs, including Medicaid, state prisons, state hospitals and county health departments," and "never meant for consumers at the pharmacy counter." So the person this was built to help was never going to see a cheaper price tag at the counter anyway. They were going to see a state that spent less on their prescriptions and had more left over for the rest of the budget. By the agency's own table, that saving is N/A too.

Here is the part the money quietly explains. The program's whole premise was that Canadian prices are lower. The thing the state did pay for, at the station's rate of about $1.2 million a month, is the warehouse, the paperwork and the standing readiness of a company to import drugs that no manufacturer has agreed to sell it. That is what you bought. Not the discount. The capacity to someday get one.

How the Machine Works

Read the report's Background and you can see every link in the chain that has to hold before a single pill crosses the border, and which one gave. The federal door is "Section 804 of the Food, Drug, and Cosmetic Act," which the report says the Medicare Modernization Act of 2003 created, and it opens only after the Secretary of Health and Human Services certifies that importing saves money and adds no risk to the public. The report says then-secretary Alex Azar certified it in 2019 and the final rule came in 2020. Each state has to design its own program and get the FDA to authorize it. And each state must line up three parties on its own: "an importer, a foreign seller, and manufacturers."

Florida got the first two. The importer is LifeScience Logistics, per the table. The foreign seller joined in April 2021, per the report, and its name is confidential, per the vendor. The third party is the one that matters, because manufacturers, in the agency's own phrase, "ultimately control the supply chain for their products." No manufacturer, no drug list, no shipment, no prescription dispensed, N/A in the box.

Notice what the contract paid for in the meantime. The statute, as the report describes it, wanted one company in the importer's chair. The station reports that nobody bid, so the agency negotiated with one company. The contract then ran, by the station's account, from Dec. 30, 2020 through a renewal two years later, across the entire stretch the report describes as the FDA sitting on Florida's application. The vendor was under contract for three years before the federal government said yes, and has been under contract for most of three more since, and the table still says N/A.

The report answers the Legislature's question with the footnote and points back at "reasons cited earlier." The reasons are real. They are also the reason the number the Legislature asked for is a dash.

The Strongest Version of the Other Side

The best case for this program is in the report, and it deserves a straight reading. "From 2020 through 2023, the FDA delayed ruling on Florida's SIP through a series of Requests for Information (RFIs) and additional administrative requirements imposed after the publication of the Final Rule." Then, in the report's words, "After two lawsuits, the FDA finally granted authorization to Florida's program in January 2024." The FDA then extended that authorization in January, July and November of 2025 and in May of 2026. Florida was the first state to get this far; the report notes Colorado became the second in June. Then the two walls the state cannot move on its own: "significant resistance from pharmaceutical manufacturers," and a Canadian government that "has expressed hesitation in supporting importation efforts out of fear that it will impact availability of medications for their citizens."

Read that way, the $82 million the station counts is the price of being ready. You cannot flip a program like this on the day the FDA finally says yes unless the importer, the warehouse and the testing chain already exist, and a state that let its vendor go in 2022 would have had no importer standing there on the day the FDA said yes. The agency fought the federal government for four years and won. The manufacturers and Ottawa are the holdouts, and neither one answers to Tallahassee.

Here is where the show gets off that train. The strongest version of the other side explains why there is no pill. It does not explain why there is no dollar figure in a quarterly report whose stated purpose is to tell the people who write the budget what the program is producing. The Legislature asked for suppliers, drug counts and prescriptions. The report gives one supplier, one confidential seller, and N/A twice. The cost of the readiness is a number the agency knows to the penny and the report does not carry at all. A reader has to get it from a television station.

What You Can Actually Do

Write the three people the report is addressed to. By the report's own first page, it goes to three readers: the Governor's budget office and the two legislators who chair appropriations in the Senate and the budget committee in the House. They wrote the proviso that asks for prescriptions dispensed. Ask them to add one line to it: dollars paid to the vendor to date, in the same table, every quarter. The agency already has that number.

Ask for the next report. The language requires one within 30 days after the end of each quarter. By that clock, the report covering July through September is due this fall. Ask whether the N/A moved.

Follow the show's request. This show has drafted a public records request to AHCA, under Florida's public records law, for the LifeScience Logistics contract, its renewal, and the payment record behind the figure ClickOrlando reported. It has not gone out yet. When it does and the documents come, the dollar figure in this piece stops being a station's reading and becomes the state's own.

Read the report yourself. It is three pages. The table is on the last one.

The So-What

The state built a bridge and paid a toll collector to stand on it for nearly five years, and nothing has ever crossed. That is not a scandal in the ordinary sense. Nobody in the report is accused of taking a dime they were not owed. The vendor was hired to be ready, the vendor is ready, and the vendor got paid.

The question this show asks is the one the Legislature wrote into the budget and the agency answered with a footnote. Who decided this was worth about $1.2 million a month, by the station's count, while the pill count sat at zero? And who, in Tallahassee, is going to be the first to put the dollar figure on the same page as the N/A, so the people paying for the bridge can see both numbers at once?

Until the report carries its own price tag, the most honest thing anyone can say about Florida's Canadian drug program is what the agency said about it. N/A.

Come back for the rest

We do this every week. The official framing on top, the receipts underneath, every figure traced back to the document it came from so you can go open it yourself and check my work. Pull up a chair, pour something cold, and let us send you the receipts before the next quiet robbery clears the courthouse. Subscribe to The Long Pour. The free newsletter where the week's little robberies and the one big one land in your inbox together.

Y'all come back, now.


The Receipts

Each claim above links to a document you can open yourself, with the access date on each line.